email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
106 - 120
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Guangzhou’s Baird Medical Completes its First Thyroid Microwave Ablation in the US
$5.00
Available
Duality and BioNTech Start China Arm of Phase III Trial of ADC for HER2 Breast Cancer
$5.00
Available
InnoCare Launches Early Access to CD19 Immunotherapy in China for B-cell Lymphoma
$5.00
Available
SineuGene Reports Positive Initial Results of RNA Therapy for ALS
$5.00
Available
AstraZeneca Signs $26.5 Million Deal to Build Production Line in China for Type-2 Diabetes Drug
$5.00
Available
CARsgen Cleared to Stage China Trial of CAR-T for Hepatocellular Carcinoma
$5.00
Available
Lee’s Pharma in $138 Million Deal for China Rights to Heart Failure Treatment
$5.00
Available
Adagene Reports Positive Early Results from its anti-CTLA-4 for Colorectal Cancer
$5.00
Available
Chipscreen NewWay Starts China Trial of PD-1/CD40 Bispecific for Solid Tumor Cancers
$5.00
Available
Henlius In-licenses Novel ESR1 Antagonist Therapy for Breast Cancer in $58 Million Deal
$5.00
Available
WuXi Biologics to Discover mAbs for BioNTech for $20 Million Upfront
$5.00
Available
GSK Pays $1.4 Billion to Acquire Aiolos, which In-Licensed a Hengrui Asthma Candidate
$5.00
Available
Bayer Joins $162 Million Round for Ji Xing; Has Preferential Rights for In-Licensings
$5.00
Available
OnCusp Completes $100 Million Series A Round for In-Licensed Cancer Candidates
$5.00
Available
Kanghua Out-Licenses Norovirus Vaccine Candidate to HilleVax in $270 Million Deal
$5.00
Available